AU2190288A - Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained - Google Patents

Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained

Info

Publication number
AU2190288A
AU2190288A AU21902/88A AU2190288A AU2190288A AU 2190288 A AU2190288 A AU 2190288A AU 21902/88 A AU21902/88 A AU 21902/88A AU 2190288 A AU2190288 A AU 2190288A AU 2190288 A AU2190288 A AU 2190288A
Authority
AU
Australia
Prior art keywords
vector
proteins
vaccine
hiv
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21902/88A
Other versions
AU622129B2 (en
Inventor
Marc Alizon
Marc Girard
Bruno Guy
Marie-Paule Kieny
Luc Montagnier
Guy Rautmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Institut Pasteur de Lille
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Publication of AU2190288A publication Critical patent/AU2190288A/en
Application granted granted Critical
Publication of AU622129B2 publication Critical patent/AU622129B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU21902/88A 1987-09-07 1988-09-07 Vector for the expression of proteins of the hiv-2 virus, one of the casual agents of aids, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained Ceased AU622129B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8712396 1987-09-07
FR8712396A FR2620030B1 (en) 1987-09-07 1987-09-07 VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED

Publications (2)

Publication Number Publication Date
AU2190288A true AU2190288A (en) 1989-03-09
AU622129B2 AU622129B2 (en) 1992-04-02

Family

ID=9354678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21902/88A Ceased AU622129B2 (en) 1987-09-07 1988-09-07 Vector for the expression of proteins of the hiv-2 virus, one of the casual agents of aids, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained

Country Status (7)

Country Link
EP (1) EP0314534A1 (en)
JP (1) JPH02448A (en)
KR (1) KR890004727A (en)
AU (1) AU622129B2 (en)
DK (1) DK495188A (en)
FR (1) FR2620030B1 (en)
PT (1) PT88430B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630861B2 (en) * 1987-11-16 1992-11-12 F. Hoffmann-La Roche Ag Recombinant hiv-2 polypeptides

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646854A1 (en) * 1989-05-12 1990-11-16 Pasteur Institut Antigens of the envelope transmembrane glycoprotein of a HIV-2 type human retrovirus, antigens exhibiting an immunological relationship with them
SG48125A1 (en) * 1989-05-12 1998-04-17 Pasteur Institut Antigenes of the envelope transmembrance glcoprotein of a human retrovirus of the hiv-2 type and antigens presenting with them an immunological relationship
WO1990015141A2 (en) * 1989-06-01 1990-12-13 Applied Biotechnology, Inc. Self-assembled, defective, non-self-propagating viral particles
FR2676071B1 (en) * 1991-05-02 1994-11-18 Transgene Sa NEW NON-CLeavABLE, SOLUBLE, HYBRID-FORMING GP160 VARIANT.
US5733720A (en) * 1992-06-18 1998-03-31 Washington University Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor
US5958676A (en) * 1992-06-18 1999-09-28 Washington University Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862412B (en) * 1985-09-25 1987-01-23 Oncogen Vaccines and immuinoassays for acquired immune deficiency syndrome
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
PT84182B (en) * 1986-01-22 1989-09-14 Pasteur Institut NEW RETROVIRUS SUSCEPTIVEL TO CAUSE AIDS, MEDIA AND PROCESSES FOR ITS DETECTION "IN VITRO"
FR2600079B1 (en) * 1986-06-16 1989-10-20 Transgene Sa VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630861B2 (en) * 1987-11-16 1992-11-12 F. Hoffmann-La Roche Ag Recombinant hiv-2 polypeptides

Also Published As

Publication number Publication date
DK495188A (en) 1989-03-08
JPH02448A (en) 1990-01-05
FR2620030B1 (en) 1990-03-23
DK495188D0 (en) 1988-09-06
FR2620030A1 (en) 1989-03-10
KR890004727A (en) 1989-05-09
EP0314534A1 (en) 1989-05-03
PT88430A (en) 1989-07-31
AU622129B2 (en) 1992-04-02
PT88430B (en) 1992-10-30

Similar Documents

Publication Publication Date Title
AU662154B2 (en) Animal derived cell with antigenic protein introduced therein
AU3933289A (en) Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast
NO892251L (en) PROCEDURE FOR THE PREPARATION OF COCOCOIDOSE VACCINE BY RECOMBINANT TECHNIQUES.
AU6891187A (en) Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
AU3636189A (en) Hiv-2 virus variants
NO912825L (en) PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IM MUNOGENT PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS.
AU571128B2 (en) Expression of immunologically reactive aids viral protein
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2056437A1 (en) Production of virus and purification of viral envelope proteins for vaccine use
WO1991015512A3 (en) Hiv envelope polypeptides
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
AU2567888A (en) Hiv peptides and methods for detection of hiv
AU630861B2 (en) Recombinant hiv-2 polypeptides
AU7412887A (en) A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
OA09653A (en) Rubella peptides
EP0311228A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
EP0293827A3 (en) Assay for leishmaniasis
AU7514087A (en) Vaccine containing the protein f of the aids virus
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
EP0345559A3 (en) Hiv-2 variants
ATE336588T1 (en) IN-VITRO PACKAGING OF ADENO-ASSOCIATED VIRUS DNA
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU3864489A (en) Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses